SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

MERIGHI, Stefania
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 20.284
AS - Asia 11.472
EU - Europa 6.568
SA - Sud America 1.749
AF - Africa 265
OC - Oceania 22
Continente sconosciuto - Info sul continente non disponibili 8
Totale 40.368
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 19.838
SG - Singapore 4.202
CN - Cina 2.973
DE - Germania 1.349
BR - Brasile 1.331
VN - Vietnam 1.272
IT - Italia 1.124
UA - Ucraina 1.014
HK - Hong Kong 944
TR - Turchia 757
GB - Regno Unito 647
FI - Finlandia 512
FR - Francia 445
SE - Svezia 377
RU - Federazione Russa 351
JP - Giappone 283
PL - Polonia 270
IN - India 236
CA - Canada 227
BD - Bangladesh 201
MX - Messico 164
AR - Argentina 152
NL - Olanda 123
ID - Indonesia 109
IQ - Iraq 98
ZA - Sudafrica 93
ES - Italia 79
CO - Colombia 56
EC - Ecuador 56
PK - Pakistan 56
LT - Lituania 51
BE - Belgio 49
VE - Venezuela 48
MA - Marocco 43
CL - Cile 38
MY - Malesia 38
SA - Arabia Saudita 37
UZ - Uzbekistan 34
AE - Emirati Arabi Uniti 32
PH - Filippine 25
AT - Austria 24
PY - Paraguay 24
TN - Tunisia 24
KE - Kenya 23
CZ - Repubblica Ceca 22
EG - Egitto 22
IL - Israele 19
AU - Australia 18
DZ - Algeria 18
NP - Nepal 18
JO - Giordania 17
KR - Corea 16
IE - Irlanda 15
PE - Perù 14
UY - Uruguay 14
BO - Bolivia 12
AL - Albania 11
TW - Taiwan 11
PT - Portogallo 10
CH - Svizzera 9
GR - Grecia 9
OM - Oman 9
RO - Romania 9
IR - Iran 8
JM - Giamaica 8
TH - Thailandia 8
AZ - Azerbaigian 7
CR - Costa Rica 7
ET - Etiopia 7
HN - Honduras 7
HU - Ungheria 7
KG - Kirghizistan 7
NI - Nicaragua 7
RS - Serbia 7
SN - Senegal 7
BG - Bulgaria 6
EU - Europa 6
GT - Guatemala 6
AO - Angola 5
BA - Bosnia-Erzegovina 5
HR - Croazia 5
KZ - Kazakistan 5
LB - Libano 5
LV - Lettonia 5
MD - Moldavia 5
NG - Nigeria 5
NO - Norvegia 5
PA - Panama 5
PS - Palestinian Territory 5
SV - El Salvador 5
AM - Armenia 4
BH - Bahrain 4
BY - Bielorussia 4
CY - Cipro 4
GE - Georgia 4
MN - Mongolia 4
QA - Qatar 4
SK - Slovacchia (Repubblica Slovacca) 4
SY - Repubblica araba siriana 4
CG - Congo 3
Totale 40.306
Salva come PNG Salva come JPEG
Città #
Singapore 2.744
Ashburn 2.175
Woodbridge 1.755
Fairfield 1.556
San Jose 1.408
Jacksonville 1.095
Chandler 1.077
Houston 1.060
Hong Kong 924
Beijing 918
Ann Arbor 878
Santa Clara 857
Seattle 662
Wilmington 643
Cambridge 533
Ho Chi Minh City 440
Dallas 413
Los Angeles 370
Izmir 366
Nanjing 336
Hanoi 311
Ferrara 309
Tokyo 266
New York 264
Princeton 255
Warsaw 243
Munich 220
Lauterbourg 219
Milan 218
Helsinki 217
Boardman 203
Council Bluffs 149
Shanghai 149
São Paulo 145
Dearborn 126
San Diego 115
Shenyang 111
Orem 109
Nanchang 105
London 99
Addison 90
Hefei 90
Tianjin 88
Mexico City 87
Montreal 86
Falkenstein 85
Bremen 82
Buffalo 82
Turku 80
Frankfurt am Main 76
Jakarta 73
Changsha 68
Chicago 64
Hebei 64
Brooklyn 62
Da Nang 62
Chennai 59
Toronto 59
Bologna 54
Haiphong 54
Jinan 49
Johannesburg 48
San Francisco 48
Atlanta 47
Brussels 47
Manchester 47
Denver 46
Jiaxing 46
Moscow 43
San Mateo 43
Stockholm 43
Poplar 42
Amsterdam 40
Boston 40
The Dalles 40
Baghdad 39
Falls Church 39
Phoenix 39
Rio de Janeiro 39
Kunming 36
Zhengzhou 36
Mountain View 35
Rome 35
Norwalk 33
Mumbai 32
Guangzhou 31
Tashkent 31
Biên Hòa 27
Auburn Hills 26
Ningbo 26
Philadelphia 26
Ankara 25
Brasília 25
Redwood City 25
Columbus 24
Belo Horizonte 23
Charlotte 23
Hải Dương 23
Medellín 22
Dhaka 21
Totale 26.918
Salva come PNG Salva come JPEG
Nome #
Pharmacology of Adenosine Receptors: The State of the Art 385
Medicinal Chemistry, Pharmacology, and Clinical Implications of TRPV1 Receptor Antagonists 329
A3 Adenosine Receptors as Modulators of Inflammation: From Medicinal Chemistry to Therapy 312
A glance at adenosine receptors: Novel target for antitumor therapy 308
Inhibition of A2A Adenosine Receptor Signaling in Cancer Cells Proliferation by the Novel Antagonist TP455 287
The A3 adenosine receptor: history and perspectives 280
A(2B) adenosine receptors stimulate IL-6 production in primary murine microglia through p38 MAPK kinase pathway 278
Positive allosteric modulation of A1 adenosine receptors as a novel and promising therapeutic strategy for anxiety 275
Pulsed Electromagnetic Field Exposure Reduces Hypoxia and Inflammation Damage in Neuron-Like and Microglial Cells 263
Characterization of adenosine receptors in bovine chondrocytes and fibroblast-like synoviocytes exposed to low frequency low energy pulsed electromagnetic fields 261
Adenosine as a Multi-Signalling Guardian Angel in Human Diseases: When, Where and How Does it Exert its Protective Effects? 260
Adenosine receptors and human melanoma 255
A1 and A3 adenosine receptors inhibit LPS-induced hypoxia-inducible factor-1 accumulation in murine astrocytes 253
[H-3]-MRE 2029-F20, a selective antagonist radioligand for the human A(2B) adenosine receptors 249
Antioxidant and antiinflammatory effects of epilobium parviflorum, melilotus officinalis and cardiospermum halicacabum plant extracts in macrophage and microglial cells 247
Effects of two-carbon bridge region methoxylation of benztropine: discovery of novel chiral ligands for the dopamine transporter 245
Effect of low frequency electromagnetic fields on A2A adenosine receptors in human neutrophils. 243
A(2A) adenosine receptors are differentially modulated by pharmacological treatments in rheumatoid arthritis patients and their stimulation ameliorates adjuvant-induced arthritis in rats 241
Role and function of A2A and A3 adenosine receptors in patients with ankylosing spondylitis, psoriatic arthritis and rheumatoid arthritis 241
[H-3]MRE 3008F20: A novel antagonist radioligand for the pharmacological and biochemical characterization of human A(3) adenosine receptors 240
Alteration of A3 adenosine receptors in human neutrophils and low frequency electromagnetic fields 237
Cannabinoid CB2 receptor attenuates morphine-induced inflammatory responses in activated microglial cells 234
Multiple sclerosis lymphocytes upregulate A(2A) adenosine receptors that are antiinflammatory when stimulated 232
Adenosine modulates vascular endothelial growth factor expression via hypoxiainducible factor-1 in human glioblastoma cells. 228
The activation of μ-opioid receptor potentiates LPS-induced NF-kB promoting an inflammatory phenotype in microglia 227
Adenosine receptors and cancer 224
HIF-1 neuroprotection through erythropoietin increase in hypoxia: a role for A1 adenosine receptors 224
Adenosine receptor targeting in health and disease 223
A3 adenosine receptors in human neutrophils and promyelocytic HL60 cells: a pharmacological and biochemical study 221
van't Hoff Based Thermodynamics 219
Adenosine receptors as mediators of both cell proliferation and cell death of cultured human melanoma cells 217
The Anti-Tumor Effect of A(3) Adenosine Receptors Is Potentiated by Pulsed Electromagnetic Fields in Cultured Neural Cancer Cells 217
Biological effects of novel 2-amino-3-naphthoylthiophenes as allosteric enhancers of the A1 adenosine receptors 216
[3H]-MRE 2029-F20, a novel selective antagonist radioligand, for the pharmacological and biochemical characterization of A2B receptors. 213
Synthesis and pharmacology of 6-substituted benztropines: Discovery of novel dopamine uptake inhibitors possessing low binding affinity to the dopamine transporter 213
M3 muscarinic receptors in peripheral lung parenchima of patients with chronic obstructive pulmonary disease. 211
A3 adenosine receptor activation inhibits cell proliferation via phosphatidylinositol 3-kinase/Akt-dependent inhibition of the extracellular signal-regulated kinase 1/2 phosphorylation in A375 human melanoma cells 210
Agonists and antagonists: Molecular mechanisms and therapeutic applications 210
Design, synthesis, and biological evaluation of new 8-heterocyclic xanthine derivatives as highly potent and selective human A(2B) adenosine receptor antagonists 209
Adenosine modulates vascular endothelial growth factor expression via hypoxia-inducible factor-1 in human glioblastoma cells 207
Pathological overproduction: the bad side of adenosine 207
Modulation of metalloproteinase-9 in U87MG glioblastoma cells by A3 adenosine receptors 207
[3H]MRE2029F20 a new selective antagonist radioligand for the human A2B adenosine receptors. 206
Adenosine and lymphocyte regulation 206
Adenosine receptors in colon carcinoma tissues and colon tumoral cell lines: focus on the A3 adenosine receptors. 204
Adenosine receptors in health and disease 204
Expression of A3 adenosine receptors in human lymphocytes: up-regulation in T cell activation 203
Targeting A3 and A2A adenosine receptors in the fight against cancer 203
THERMODYNAMICS OF A2B ADENOSINE RECEPTOR BINDING DISCRIMINATES AGONISTIC FROM ANTAGONISTIC BEHAVIOUR 202
Water-Soluble Pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidines as Human A3 Adenosine Receptor Antagonists 202
A3 adenosine receptors in human neutrophils and promyelocytic HL60 cells: A pharmacological and biochemical study. 202
Pharmacological and biochemical characterization of adenosine receptors in the human malignant melanoma A375 cell line. 200
Effect of low frequency electromagnetic fields on A2A adenosine receptors in human neutrophils. 200
Receptor binding thermodynamics as a tool for linking drug efficacy and affinity 199
[3H]-MRE 3008-F20: a novel antagonist radioligand for the pharmacological and biochemical characterization of human A3 adenosine receptors. 199
Adenosine Receptors as a Biological Pathway for the Anti-Inflammatory and Beneficial Effects of Low Frequency Low Energy Pulsed Electromagnetic Fields 199
Pharmacological characterization of novel adenosine ligands in recombinant and native human A2B receptors 198
Binding thermodynamic characterization of human P2X1 and P2X3 purinergic receptors 197
Pharmacological characterization of adenosine receptors in bovine chondrocytes. 195
Synthesis, molecular modeling and SAR study of novel pyrazolo[5,1-f][1,6]naphthyridines as CB2receptor antagonists/inverse agonists 195
A3 adenosine receptors in human neutrophils and promyelocitic HL60 cells: a pharmacological and biochemical study. 193
Thermodynamic analysis in drug-receptor binding: the A3 adenosine receptor 193
Pulsed electromagnetic field and relief of hypoxia-induced neuronal cell death: The signaling pathway 193
Thermodynamics of A2B adenosine receptor binding discriminates agonistic from antagonistic behaviour 192
Binding thermodynamics at the human cannabinoid CB1 and CB2 receptors 192
Adenosine receptors as mediators of both cell proliferation and cell death of cultured human melanoma cells. 192
Pyrazolotriazolopyrimidine derivatives sensitize melanoma cells to the chemiotherapic drugs: taxol and vindesine. 191
Adenosine modulates HIF-1, VEGF, IL-8 and foam cells formation in a human model of hypoxic foam cells 191
Biochemical and pharmacological role of A1adenosine receptors and their modulation as novel therapeutic strategy 191
New pyrrolo[2,1-f]purine-2,4-dione and imidazo[2,1-f]purine-2,4-dione derivatives as potent and selective human A(3) adenosine receptor antagonists 190
A(2A) adenosine receptors in human peripheral blood cells 190
Adenosine in a human model of Hypoxic foam cells 190
[3H]MRE3008-F20: a novel antagonist radioligand for the pharmacological and biochemical characterization of human A3 adenosine receptors. 190
Effect of low frequency electromagnetic fields on A2A adenosine receptors in human neutrophils. 189
Caffeine inhibits adenosine-induced accumulation of hypoxia-inducible factor-1α, vascular endothelial growth factor, and interleukin-8 expression in hypoxic human colon cancer cells 187
New potent and selective human adenosine A3 receptor antagonists. 185
Effect of low frequency electromagnetic fields on A2A and A3 adenosine receptors in human neutrophils 182
MODULATION OF MMP-9 IN U87MG GLIOBLASTOMA CELLS BY A3 ADENOSINE RECEPTORS 182
A2A Adenosine Receptor as a Potential Biomarker and a Possible Therapeutic Target in Alzheimer's Disease 181
L'ipossia inibisce l'apoptosi indotta da paclitaxel mediante fosforilazione di BAD dipendente dall'adenosina nelle cellule di glioblastoma. 179
Adenosine modulates HIF-1α, VEGF, IL-8, and foam cell formation in a human model of hypoxic foam cells 179
Hydrogen sulfide modulates the release of nitric oxide and VEGF in human keratinocytes. 179
Adenosine receptors as mediators of both cell proliferation and cell death of cultured human melanoma cells. 178
Hypoxia inhibits paclitaxel-induced apoptosis through adenosine-mediated phosphorylation of bad in glioblastoma cells 178
New potent and selective human adenosine A3 receptor antagonists 178
Pharmacological and biochemical characterization of A3 adenosine receptors in Jurkat T cells. 177
Binding and functional parameters of A2A adenosine receptors in essential hypertensive patients before and after pharmacological treatment 177
MODULATION OF THE AKT/RAS/RAF/MEK/ERK PATHWAY BY A3 ADENOSINE RECEPTOR 177
The A3 adenosine receptor: An enigmatic player in cell biology 176
Design, synthesis, and biological evaluation of C-9- and C-2-substituted pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c] pyrimidines as new A(2A) and A(3) adenosine receptors antagonists 176
[3H]-MRE 2029-F20, A Novel Selective Antagonist Radiolig and, for the Pharmacological and Biochemical Characterization of A2B Receptors. 176
Pharmacological characterization of novel adenosine ligands in recombinant and native human A2B receptors 175
Recettori dell'adenosina in tessuti tumorali e in linee cellulari di colon:"focus" sul recettore A3. 175
Synthesis and activity of 3-pyridylamine ligands at central nicotinic receptors 175
Expression, pharmacological profile and functional coupling of A2B receptors in a recombinant system and in peripheral blood cells by using a novel selective antagonist radioligand, [3H]MRE2029F20. 175
Cannabinoid CB2 receptor modulates microglial cell activation: role of ERK-1/2 Kinase signaling. 175
Adenosine receptors in bovine chondrocytes and fibroblast-like synoviocytes 173
Effect of low frequency electromagnetic fields on A2A and A3 adenosine receptors in human neutrophils 173
A3 ADENOSINE RECEPTORS MODULATE HYPOXIA-INDUCIBLE FACTOR-1ALPHA EXPRESSION IN HUMAN CANCER CELLS 172
Signaling pathways involved in anti-inflammatory effects of Pulsed Electromagnetic Field in microglial cells 172
Totale 21.161
Salva come PNG Salva come JPEG
Categoria #
all - tutte 167.834
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 6.734
Totale 174.568
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021526 0 0 0 0 0 0 0 0 0 0 369 157
2021/20222.157 45 228 152 75 84 97 81 104 76 183 322 710
2022/20232.535 245 223 91 337 424 325 140 203 291 24 143 89
2023/20241.272 113 168 44 27 131 139 53 93 32 54 65 353
2024/20255.622 128 192 419 289 701 522 246 315 741 638 786 645
2025/202615.646 1.635 571 1.351 1.978 2.329 1.110 1.903 797 1.611 1.788 573 0
Totale 40.701